Baker Avenue Asset Management LP grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.1% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,273 shares of the healthcare conglomerate’s stock after acquiring an additional 610 shares during the quarter. Baker Avenue Asset Management LP’s holdings in UnitedHealth Group were worth $978,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Marshall Wace LLP increased its stake in shares of UnitedHealth Group by 441.4% in the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after acquiring an additional 11,361 shares during the last quarter. American Century Companies Inc. increased its stake in shares of UnitedHealth Group by 16.9% in the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after acquiring an additional 681,111 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after purchasing an additional 183,401 shares during the last quarter. Essex Financial Services Inc. increased its position in shares of UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after purchasing an additional 967 shares during the last quarter. Finally, Factory Mutual Insurance Co. increased its position in shares of UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after purchasing an additional 72,000 shares during the last quarter. 86.20% of the stock is owned by institutional investors and hedge funds.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $1.39 during trading on Friday, reaching $226.78. The company had a trading volume of 3,326,053 shares, compared to its average volume of 2,316,383. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market cap of $221,112.13, a PE ratio of 23.77, a price-to-earnings-growth ratio of 1.69 and a beta of 0.65. UnitedHealth Group Incorporated has a 12 month low of $156.09 and a 12 month high of $229.22.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.17 EPS. equities research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s payout ratio is presently 33.26%.

UNH has been the subject of a number of recent analyst reports. UBS reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley raised their price objective on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Leerink Swann reissued a “buy” rating and set a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $224.56.

In other news, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders sold a total of 63,206 shares of company stock valued at $12,683,669 in the last quarter. Company insiders own 0.89% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/12/02/baker-avenue-asset-management-lp-buys-610-shares-of-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.